Gilead Sciences GILD
NASDAQ GILD
$145.69 -0.95 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Gilead Sciences (GILD) Current Taxes (2009 - 2015)

Gilead Sciences' (GILD) quarterly Current Taxes came in at $356.0 million in Q2 2015, up 265.87% on a YoY basis from $97.3 million in Q2 2014, and up 263.27% quarter-over-quarter from $98.0 million in Q1 2015.

Analysis

Gilead Sciences (GILD) Current Taxes (2009 - 2015) Analysis & Trends

Gilead Sciences (GILD) has reported Current Taxes for 7 consecutive years, with $356.0 million the latest figure, recorded in Q2 2015.

  • For the quarter ending Q2 2015, Current Taxes rose 265.87% year-over-year to $356.0 million; the trailing twelve-month figure through Jun 2015 stood at $356.0 million (up 265.87% YoY), and the FY2014 full-year result was $105.0 million, up 854.55% from the prior year.
  • Current Taxes grew to $356.0 million in Q2 2015 per GILD's latest filing, from $98.0 million in the prior quarter.
  • Across five years, Current Taxes topped out at $356.0 million in Q2 2015 and bottomed at $2.5 million in Q1 2011.
  • Historically, Current Taxes has averaged $59.5 million across 5 years, with a median of $26.5 million in 2011.
  • The widest YoY moves for Current Taxes: up 2079.54% in 2011, down 93.62% in 2011.
  • Over 5 years, Current Taxes stood at $40.6 million in 2011, then sank by 66.97% to $13.4 million in 2012, then declined by 17.93% to $11.0 million in 2013, then surged by 854.55% to $105.0 million in 2014, then soared by 239.05% to $356.0 million in 2015.
  • According to Business Quant data, Current Taxes over the past three periods registered $356.0 million, $98.0 million, and $105.0 million for Q2 2015, Q1 2015, and Q4 2014 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 49.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 86.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn 24.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 356.00 Mn
Mar 31, 2015 98.00 Mn
Dec 31, 2014 105.00 Mn
Sep 30, 2014 43.78 Mn
Jun 30, 2014 97.30 Mn
Mar 31, 2014 152.95 Mn
Dec 31, 2013 11.00 Mn
Sep 30, 2013 10.65 Mn
Jun 30, 2013 37.97 Mn
Mar 31, 2013 19.24 Mn
Dec 31, 2012 13.40 Mn
Sep 30, 2012 17.09 Mn
Jun 30, 2012 11.85 Mn
Mar 31, 2012 14.49 Mn
Dec 31, 2011 40.58 Mn
Sep 30, 2011 33.67 Mn
Jun 30, 2011 5.44 Mn
Mar 31, 2011 2.46 Mn
Dec 31, 2010 1.86 Mn
Sep 30, 2010 38.71 Mn